Identification of the major photodegradant in metronidazole by LC-PDA-MS and its reveal in compendial methods

Mei-Ling Chen1, Hong-Xia Xu1, Wei-Feng Yuan1

  • 1Beijing Sun-Novo Pharmaceutical Research Company Ltd, Yunguyuan, No.79 Shuangying West Road, Changping District, Beijing, 102200, People's Republic of China.

Scientific Reports
|July 8, 2022
PubMed

Insights

Metronidazole degrades under light, forming a specific compound. Current tests miss this photolytic impurity, but an improved liquid chromatography method can now detect it.

Area of Science:

  • Pharmaceutical analysis
  • Photochemistry

Background:

  • Metronidazole is susceptible to photodegradation in aqueous solutions.
  • Existing compendial methods fail to detect photolytic degradants.

Purpose of the Study:

  • To identify and quantify metronidazole photolytic degradants.
  • To develop and validate an improved analytical method for metronidazole impurity profiling.

Main Methods:

  • Liquid chromatography with tandem photo diode array detection and mass spectrometry (LC-PDA-MS).
  • Proton nuclear magnetic resonance (1H-NMR) spectroscopy for structural verification.
  • Development and validation of an optimized liquid chromatography (LC) method.

Main Results:

  • Identified N-(2-hydroxyethyl)-5-methyl-l,2,4-oxadiazole-3-carboxamide as a photolytic degradant of metronidazole.
  • Demonstrated the inability of current compendial tests to detect this impurity.
  • Developed a validated LC method with enhanced separation using a 230 nm detection wavelength and optimized mobile phase.

Conclusions:

  • Metronidazole photodegradation products are not detected by current standard tests.
  • An improved LC method is necessary for accurate impurity profiling of metronidazole, especially concerning photolytic degradation.

Related Concept Videos